We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 14.47%
2 Healthcare 12.77%
3 Financials 11.42%
4 Technology 10.65%
5 Consumer Discretionary 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKD icon
776
Brookdale Senior Living
BKD
$2.79B
$550K 0.02%
44,301
-14,599
-25% -$196K
XRT icon
777
State Street SPDR S&P Retail ETF
XRT
$393M
$550K 0.02%
12,489
+7,812
+167% +$347K
FPRX
778
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$549K 0.02%
10,957
-453
-4% -$23.8K
JBLU icon
779
JetBlue
JBLU
$1.62B
$547K 0.02%
+24,418
New +$482K
HIW icon
780
Highwoods Properties
HIW
$3.39B
$546K 0.02%
10,700
+2,525
+31% +$124K
WOOF
781
DELISTED
VCA Inc.
WOOF
$546K 0.02%
7,946
+816
+11% +$53.3K
ORBK
782
DELISTED
Orbotech Ltd
ORBK
$543K 0.02%
16,243
+69
+0.4% +$2.11K
USA icon
783
Liberty All-Star Equity Fund
USA
$1.82B
$536K 0.02%
103,867
+4,050
+4% +$20.5K
EOD
784
Allspring Global Dividend Opportunity Fund
EOD
$275M
$533K 0.02%
97,788
+6,078
+7% +$33K
INGN icon
785
Inogen
INGN
$136M
$531K 0.02%
7,900
-1,300
-14% -$80.2K
PSEC icon
786
Prospect Capital
PSEC
$1.13B
$530K 0.02%
63,397
+1,400
+2% +$11.2K
TA
787
DELISTED
TravelCenters of America LLC
TA
$530K 0.02%
14,920
-330
-2% -$11.2K
ADUS icon
788
Addus HomeCare
ADUS
$2.21B
$526K 0.02%
+15,000
New +$462K
CCL icon
789
Carnival Corporation Ltd
CCL
$30.6B
$526K 0.02%
10,104
+5,683
+129% +$284K
BSX icon
790
Boston Scientific
BSX
$63.6B
$525K 0.02%
24,303
+13,038
+116% +$284K
OEF icon
791
iShares S&P 100 ETF
OEF
$20B
$525K 0.02%
5,289
-521
-9% -$50.5K
PTCT icon
792
PTC Therapeutics
PTCT
$5.64B
$525K 0.02%
48,160
-2,552
-5% -$26.8K
XL
793
DELISTED
XL Group Ltd.
XL
$524K 0.02%
14,072
+3,372
+32% +$121K
TD icon
794
Toronto Dominion Bank
TD
$198B
$522K 0.02%
10,576
+3,860
+57% +$180K
WNC icon
795
Wabash National
WNC
$482M
$520K 0.02%
32,916
-5,391
-14% -$73.5K
WGL
796
DELISTED
Wgl Holdings
WGL
$520K 0.02%
6,812
+150
+2% +$10.1K
FNX icon
797
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.34B
$518K 0.02%
9,186
-121
-1% -$6.54K
DFIN icon
798
Donnelley Financial Solutions
DFIN
$1.2B
$517K 0.02%
+22,512
New +$477K
WHR icon
799
Whirlpool
WHR
$2.11B
$516K 0.02%
2,840
+452
+19% +$74.8K
PPG icon
800
PPG Industries
PPG
$23.3B
$513K 0.01%
5,410
-402
-7% -$38.4K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.